Evaluating the Minimal Clinically Important Difference of the King'S Sarcoidosis Questionnaire (KSQ) in a Multi-Center, Prospective Trial
R.P. Baughman(University of Cincinnati), SS Birring(King's College Hospital), Jennifer L. Beaumont(Northwestern University), E.S. Chen(Johns Hopkins University), Nabeel Hamzeh(American Thoracic Society), Elyse E. Lower(University of Cincinnati), Lisa A. Maier(National Jewish Health), Nadera Sweiss(University of Illinois Chicago), Daniel A. Culver(Cleveland Clinic), Marc A. Judson(Cleveland Clinic), Noopur Singh(Pulmonary Fibrosis Foundation)
Cited by 1
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Practice Guidelines for Diseases Caused by Aspergillus
|Clinical Infectious Diseases|2000|797
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579